UNFPA Armenia Presented the “Prevalence and Reasons of Sex Selective Abortions in Armenia” Report
By Public Radio of Armenia,
Public Radio of Armenia
| 12. 19. 2011
Prof. Razmik Abrahamyan, Director of Institute of Reproductive Health, Perinatology, Obstetrics and Gynecology, and Mr. Garik Hayrapetyan, UNFPA Armenia Assistant Representative presented the “Prevalence and Reasons of Sex Selective Abortions in Armenia” Report today.
As the speakers noted, the report contained both positive and alarming findings. In particular, the majority of the surveyed women have started having children in a favorable reproductive age: from 19 to 35 years old, which is very important in terms of safe motherhood. Another extremely positive finding is that the Armenian society provides the same care to already born children irrespective of their sex.
However, as to the future children, the society prefers boys much more than girls – around six times. The study suggests that 0.8 per cent of 900,000 Armenian women of reproductive age have had a sex selective abortion in the last five years. This means that each year Armenia potentially loses around 1400 future mothers.
According to the speakers, the report is based on the findings of a quantitative survey of 2830 households in the period of July 15-August 15, 2011...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
By Grace Won, KQED Forum [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
